ID: ALA3577745

Max Phase: Preclinical

Molecular Formula: C19H16BrClN2

Molecular Weight: 307.80

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c2[nH]c3ccccc3c2cc[n+]1Cc1ccc(Cl)cc1.[Br-]

Standard InChI:  InChI=1S/C19H15ClN2.BrH/c1-13-19-17(16-4-2-3-5-18(16)21-19)10-11-22(13)12-14-6-8-15(20)9-7-14;/h2-11H,12H2,1H3;1H

Standard InChI Key:  HCSXDSISIFICIY-UHFFFAOYSA-N

Associated Targets(non-human)

Chitinase 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.80Molecular Weight (Monoisotopic): 307.0997AlogP: 4.62#Rotatable Bonds: 2
Polar Surface Area: 19.67Molecular Species: NEUTRALHBA: 0HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.93CX Basic pKa: CX LogP: -0.08CX LogD: -0.08
Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.52Np Likeness Score: -0.02

References

1. Gooyit M, Tricoche N, Javor S, Lustigman S, Janda KD..  (2015)  Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.,  (3): [PMID:25815157] [10.1021/ml500516r]

Source